title: Ro 16-6028: a novel anxiolytic acting as a partial agonist at the benzodiazepine receptor.
authors.affiliation: Pharmaceutical Research Department, F. Hoffmann-La Roche & Co., Ltd., Basel, Switzerland.
authors.forename: J R
authors.initials: JR
authors.lastname: Martin
authors.forename: L
authors.initials: L
authors.lastname: Pieri
authors.forename: E P
authors.initials: EP
authors.lastname: Bonetti
authors.forename: R
authors.initials: R
authors.lastname: Schaffner
authors.forename: W P
authors.initials: WP
authors.lastname: Burkard
authors.forename: R
authors.initials: R
authors.lastname: Cumin
authors.forename: W E
authors.initials: WE
authors.lastname: Haefely
mesh_terms: D000818:Animals; D014151:Anti-Anxiety Agents / Q000494:pharmacology*; D000927:Anticonvulsants; D001522:Behavior, Animal / Q000187:drug effects*; D001570:Benzodiazepinones / Q000494:pharmacology*; D002415:Cats; D003220:Conflict, Psychological; D006152:Cyclic GMP / Q000378:metabolism; D003975:Diazepam / Q000037:antagonists & inhibitors; D004285:Dogs; D005445:Flunitrazepam / Q000037:antagonists & inhibitors; D051379:Mice; D051381:Rats; D011963:Receptors, GABA-A / Q000187:drug effects*; D012453:Saimiri; D013375:Substance Withdrawal Syndrome / Q000503:physiopathology
chemical_list: D014151:Anti-Anxiety Agents; D000927:Anticonvulsants; D001570:Benzodiazepinones; D011963:Receptors, GABA-A; D005445:Flunitrazepam; D006152:Cyclic GMP; C054626:bretazenil; D003975:Diazepam